Statement by Ambassador Hiroyuki Minami, in charge of International Cooperation for Countering Terrorism and International Organized Crime on agenda item 3 (general debate) at the high-level segment of 67th Commission on Narcotic Drugs (CND)

H.E. Amassador Philbert Abaka Johnson,
H.E. Madame Ghada Fathi Waly,
Excellencies, Distinguished Ministers, Delegates, and Partners,

I have the honor of delivering this statement on behalf of the Government of Japan.

First of all, I would like to congratulate you, Ambassador Johnson, on your election as Chair, and all the members of the Bureau on your election as well.
I also express my sincere gratitude for the Secretariat who devote their efforts to the coordination of the sessions of the 67th Commission.

Mr. Chair,

As we gather here today to press forward with measures, it is imperative to recognize the significant contributions collectively made to date by the Member States in combatting global challenge.

We all recognize the grave impact of drug abuse on individuals, families, communities, societies, and environment. In that regard, we recognize that the issues require a comprehensive approach that encompasses prevention, treatment, rehabilitation, and law enforcement efforts, with its steadfast commitment to international and regional cooperation for our unrelented efforts, aiming to stand as a beacon of our hope in the fight against drug-related threats on life and environment.

We also acknowledge what we shall do first and foremost to build and implement measures, however, transnational crime organizations cash in on political instability and vulnerabilities, underlying illicit manufacturing and trafficking, increasing challenges to respond to essential medicinal care needs.

Synthetic drug threats are one of our most pressing agendas for which we need to be innovative to tackle with vertical and horizontal promptness and efficacy.

Thus, as we look to the future, it is imperative that we build upon our exemplary efforts and forge ahead with renewed determination and solidarity. The scourge of drug issues knows NO border, and only through collective action and shared responsibility, we can overcome it.

Mr. Chair,

With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenges that both the range of drugs and drugs markets are expanding and diversifying; and the abuse, illicit cultivation and production and manufacture of narcotic drugs and psychotropic substances, as well as the illicit trafficking in those substances and in precursors, have reached record levels, and that the illicit demand for and the diversion of precursor chemicals are on the rise; I pledge for JAPAN to implement the projects, with our special focus on;
  • Strengthening capabilities of the border-management law enforcement agencies, such as the Customs, Border Guards, Police, Drug Control Agencies, serving at borders of countries neighboring Afghanistan and Ukraine through exchange of operational information under the Inter-Regional Network of Customs Authorities and Port Control Units against trafficking in narcotics and other contraband in the regions, whilst facilitating the legitimate trade, and;
  • Strengthening Maritime Security and the Rule of Law at Sea toward a Free and Open Indo-Pacific to enhance regional cooperation between Western Indian Ocean States on maritime law enforcement, and expertise to counter emerging maritime crime issues, including drug trafficking.
Moreover, in addressing the challenges that drug treatment and health services continue to fall short of meeting needs and deaths related to drug use have increased; I pledge for JAPAN to implement the projects additionally for;
  • Scaling up emergency humanitarian and health responses to internal displacement in the Mekong border countries, with the focus to specific vulnerability of border areas, communities or migrants’ camps to the risks involved drug-related offenses and the accessibility to the available treatment and care for drug-related health issues.
To support implementation of activities encompassed to achieve the objectives primarily set for 2025, we decide to contribute more than 8 million dollars.

Mr. Chair,

To this end, Japan will continue to work closely with the UNODC and collaborate with the Member States, to strengthen drug control measures, to continue enhancement of capacity-building efforts and support alternative, social and health development measures, in line with the principles and objectives of the three international drug conventions.

I thank you.